Qlife Holding AB (ST:QLIFE) — Market Cap & Net Worth
Market Cap & Net Worth: Qlife Holding AB (QLIFE)
Qlife Holding AB (ST:QLIFE) has a market capitalization of $6.70 Million (Skr62.26 Million) as of June 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #27973 globally and #620 in its home market, demonstrating a -7.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Qlife Holding AB's stock price Skr1.97 by its total outstanding shares 31636514 (31.64 Million). Review Qlife Holding AB (QLIFE) total liabilities to assess the company's total debt and financial obligations.
Qlife Holding AB Market Cap History: 2020 to 2026
Qlife Holding AB's market capitalization history from 2020 to 2026. Data shows change from $22.32 Billion to $6.70 Million (-68.04% CAGR).
Index Memberships
Qlife Holding AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.84 Billion | 0.04% | #179 of 281 |
Weight: Qlife Holding AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Qlife Holding AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Qlife Holding AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
29.84x
Qlife Holding AB's market cap is 29.84 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $22.32 Billion | $20.75 Million | -$20.20 Million | 1075.77x | N/A |
| 2021 | $32.09 Billion | $39.61 Million | -$38.80 Million | 810.05x | N/A |
| 2022 | $2.18 Billion | $17.99 Million | -$93.14 Million | 121.21x | N/A |
| 2023 | $84.52 Million | $244.00K | -$159.96 Million | 346.41x | N/A |
| 2024 | $6.88 Million | $50.00K | -$55.98 Million | 137.55x | N/A |
| 2025 | $9.67 Million | $324.00K | -$20.56 Million | 29.84x | N/A |
Competitor Companies of QLIFE by Market Capitalization
Companies near Qlife Holding AB in the global market cap rankings as of June 19, 2026.
Key companies related to Qlife Holding AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Qlife Holding AB Historical Marketcap From 2020 to 2026
Between 2020 and today, Qlife Holding AB's market cap moved from $22.32 Billion to $ 6.70 Million, with a yearly change of -68.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr6.70 Million | -30.70% |
| 2025 | Skr9.67 Million | +40.59% |
| 2024 | Skr6.88 Million | -91.86% |
| 2023 | Skr84.52 Million | -96.12% |
| 2022 | Skr2.18 Billion | -93.20% |
| 2021 | Skr32.09 Billion | +43.75% |
| 2020 | Skr22.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Qlife Holding AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.70 Million USD |
| MoneyControl | $6.70 Million USD |
| MarketWatch | $6.70 Million USD |
| marketcap.company | $6.70 Million USD |
| Reuters | $6.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Qlife Holding AB
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Qlife Holding AB (publ) was incorporated in 2019 and is based in Gothenburg, Sweden.